(Reuters) – Europe’s medicines regulator has added a rare nerve-damaging disorder, Guillain-Barré syndrome, as a possible side-effect of AstraZeneca’s COVID-19 vaccine, regular safety updates from the watchdog showed on Wednesday.
The European Medicines Agency also tagged some other less severe side-effects to vaccines from Johnson & Johnson, Moderna as well as AstraZeneca’s shot.
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Shinjini Ganguli)
